KDL Biotech (Delisted) share news and announcements
BSE: 532291
Formerly Kopran Drugs
Last traded ₹2.14 on 16 Mar 2015
Delisted on 11 May 2018.
KDL Biotech share news and announcements
172 announcements, routine notices left out, newest first. Page 2 of 4.
May 2012
5 May · Board meeting
To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2012.
Feb 2012
18 Feb · Limited Review for Dec 31, 2011
7 Feb · Board meeting
To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended December 31, 2011.
Nov 2011
3 Nov · Board meeting
To consider inter alia the half year and quarter ended September 30, 2011 Un-audited Financial Results of the Company.
Oct 2011
3 Oct · Meeting
Members at the 24th Annual General Meeting (AGM) of the Company held on September 28, 2011, inter alia, have transacted the following: 1. ....
Sep 2011
23 Sep · Meeting
S the Annual General Meeting of the Member of the Company is scheduled to be held on September 28, 2011.22 Sep · Meeting
The 24th Annual General Meeting (AGM) of the Company will be held on September 28, 2011 at 11.30 a.m. at the Registered Office of the Company at Village ....16 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2011 to September 28, 2011 (both days inclusive) ....14 Sep · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 24, 2011 to September 28, 2011 (both days inclusive) for the purpose of Annual General Meeting of the Company.
Aug 2011
19 Aug · Board meeting
Board of Directors of the Company in their Meeting held on August 17, 2011 has transacted the following business: (1) Fixed date of Annual General Meeting as September 28, 2011 and approved the notice of Annual General Meeting.(2) Accepted the Resignation given by Mr. Harish Bhardwaj, Director of the Company from the Board of Directors.18 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 17, 2011, has transacted the following business: 1. Fixed the date of twenty-fourth ....12 Aug · Board meeting
Company had informed the Exchange regarding Meeting of the Board of Directors of the Company scheduled to be held on August 12, 2011 to transact the following business : (1) To take on record Audited Financial Results for the Accounting Period ended on March 31, 2011; (2) To Consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30, 2011; (3) Any other matter with the permission of the Chair. The Company has now informed the Exchange that the Board Meeting of the Company which was scheduled to be held on August 12, 2011 has been adjourned due to lack of qorum and the same will now be held on August 17, 2011.3 Aug · Board meeting
To transact the following business : (1) To take on record Audited Financial Results for the Accounting Period ended on March 31, 2011; (2) To Consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30, 2011; (3) Any other matter with the permission of the Chair.
Jul 2011
7 Jul · Registration of the Company with BIFR
Company had made a reference to the Board for Industrial and Financial Reconstruction (BIFR) under Section 15(1) of the Sick Industrial Companies ....7 Jul · Updates
Company had made a reference to the Board for Industrial and Financial Reconstruction (BIFR) under Section 15(1) of the Sick Industrial Companies (Special provisions) Act, 1985. The reference has been registered in BIFR as Case No.35/2011.
Jun 2011
2 Jun · Price & Volume movement
Price & Volume movement : Significant price and volume movement has been observed in KDL Biotech Limited . The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. KDL Biotech Limited has vide its letter inter-alia stated, "There is no information or announcement that could have a bearing on the operation or the performance of the company which has not been intimated to the exchange in terms of the listing agreement."2 Jun · Legal
With reference to increase in Price and Volume, Kdl Biotech Ltd has clarified to BSE that, as of the date, there is no additional information or announcement that could have a bearing on ....
May 2011
12 May · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 12, 2011 to consider inter alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2011. The Company has now informed the Exchange that the aforesaid Board Meeting which was held on May 12, 2011 has been adjourned and will be held on May 13, 2011.2 May · Board meeting
To consider inter alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2011.
Apr 2011
Feb 2011
23 Feb · Limited Review for the quarter ended Dec 31, 2010
21 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2010 A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Feb · Board meeting
To consider inter alia the Un-audited Financial Results of the Company for the quarter ended December 31, 2010.
Nov 2010
25 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Nov · Limited Review for the quarter ended Sep 30, 2010
4 Nov · Board meeting
Kdl Biotech Ltd has now informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2010, have approved the revised draft of code of conduct for prevention ....
Oct 2010
8 Oct · Board meeting
To consider inter alia the Un-audited Financial Results of the Company for the quarter ended September 30, 2010.
Aug 2010
26 Aug · Limited Review for the quarter ended Jun 30, 2010
Auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2010.18 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.